EOEsin Ozcelebi

Esin Ozcelebi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Esin Ozcelebi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Omega-3–rich fish oil lipid emulsions significantly prevent sepsis-driven mesenteric hypoperfusion and multi-organ injury in murine models

    by Gökşen Öz, Esi̇n Özçelebi̇, Ayşe Yeşi̇m Göçmen, Cenk Sükmensüer, Selma Yildirim, Arzu Topeli̇, Alper Bektaş İsKi̇t

    Background/aim: Parenteral feeding is used in critically ill patients when enteral nutrition is inadequate or intolerable, and the gastrointestinal tract is not functioning properly. Lipid emulsions play a major role in parenteral nutrition because they supply necessary fatty acids and a high-calorie density. We investigated the effects of parenteral lipid emulsions on mesenteric perfusion, inflammation-induced oxidation, and organ damage in lipopolysaccharide-induced mice endotoxemia model. Materials and methods: In septic mice, organ damage induced by lipopolysaccharide was assessed by histopathology and biochemical examination. Additionally, an ultrasonic blood flowmeter was used to measure the impact of lipid emulsions on mesenteric blood flow. Results: When compared to control animals, mesenteric blood flow was reduced by parenteral lipid emulsions containing fish oil, soybean oil, and olive oil; however, when compared to the lipopolysaccharide group, the decrease in mesenteric blood flow was avoided by fish oil therapy. Lipid emulsions could not hinder the increase in liver and spleen weight caused by lipopolysaccharide injection. In septic mice, fish oil reduced liver damage, whereas in control animals, specific dosages of olive and soybean oils resulted in histopathologically significant liver and spleen damage. Parenteral lipid emulsions have shown an organ-specific impact on compromised oxidative equilibrium. Conclusion: Fish oil emulsions containing high omega-3 fatty acids abrogate the decrease in mesenteric blood flow and prevent liver damage in this experimental endotoxemia model.

  • In vitro effects of β3‐adrenoceptor agonist mirabegron on the human ureter

    by Meylis Artykov, Esin Ozcelebi, Mehmet Yildirim Sara, Ahmet Gudeloglu, Alper Bektas Iskit, Fazil Tuncay Aki

    Introduction: This study aimed to investigate the effect of mirabegron, a β3‐adrenoceptor agonist with widespread clinical use for treating overactive bladder disease, on isolated healthy human ureter strips.Materials and Methods: This was a prospective study employing a series of in vitro organ bath experiments using ureteral tissues of kidney grafts from 10 healthy donors. The ureteral strips were subjected to cumulative mirabegron concentrations (10−9–10−4.5 M). Effects on frequency or amplitude of spontaneous, 10 mM KCl‐ or EFS‐induced contractions were evaluated.Results: Mirabegron decreased the frequency of spontaneous ureteric contraction in a concentration‐dependent manner. Statistically significant decrease in the frequency of spontaneous contraction was observed at 10−8–10−4.5 M. In 10 mM KCl medium, statistically significant change in frequency was observed at 10−9–10−4.5 M. Statistically significant decrease in the amplitudes of spontaneous contraction was observed at 10−7–10−4.5 M. In a 10 mM KCl medium, statistically significant change in amplitudes was observed at 10−8–10−4.5 M.Conclusions: Mirabegron reduced the amplitude and frequency of human ureter activity in in vitro organ bath studies. This effect was achieved in a dose‐dependent manner on isolated tissue strips. Although monotherapy with mirabegron remains uncertain, this study has the potential to elucidate the mechanism underlying the effectiveness of mirabegron, particularly in combination therapy for ureteral stones.


  • Alamandine treatment prevents LPS-induced acute renal and systemic dysfunction with multi-organ injury in rats via inhibiting iNOS expression

    by H. Saltuk Songür, Sinan Alperen Kaya, Yaşar Can Altınışık, Rukiye Abanoz, Esin Özçelebi, Füsun Özmen, Kemal Kösemehmetoğlu, Güray Soydan